Decreased incidence of nonspecific interstitial pneumonitis in children with acute lymphocytic leukemia treated prophylactically with trimethoprim-sulfamethoxazole.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004338:Drug Combinations; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D011020:Pneumonia, Pneumocystis / Q000209:etiology / Q000517:prevention & control; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000517:prevention & control*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole